The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2, open-label dose-escalation study of liposomal irinotecan (nal-IRI) plus 5- fluorouracil/leucovorin (5-FU/LV) and oxaliplatin (OX) in patients with previously untreated metastatic pancreatic cancer (mPAC).
 
Andrew Peter Dean
Honoraria - Specialised Therapeutics
Consulting or Advisory Role - Baxalta; Celgene
 
Zev A. Wainberg
Consulting or Advisory Role - Aduro Biotech; Array BioPharma; Bristol-Myers Squibb; Five Prime Therapeutics; Genentech; Lilly; Merck; Merck KGaA; Novartis; Sirtex Medical
Research Funding - Five Prime Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Genentech
 
Ramesh K. Ramanathan
Honoraria - Insys Therapeutics; Novocure; Pharmacyclics
Consulting or Advisory Role - Cerulean Pharma; Insys Therapeutics; Novocure; Pharmacyclics
Research Funding - Abbvie (Inst); Berg Pharma (Inst); Boston Biomedical (Inst); Celgene (Inst); Ipsen (Inst); Merck/Schering Plough (Inst); Merrimack (Inst); Superlab Far East (Inst)
 
Patrick McKay Boland
Honoraria - Boston Biomedical
Consulting or Advisory Role - Merrimack; Sirtex Medical
Research Funding - Advaxis (Inst); Athenex (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Genentech/Roche (Inst); Ipsen (Inst); Merck (Inst); Merrimack (Inst); Theradiag (Inst)
 
Kabir Mody
Consulting or Advisory Role - AstraZeneca; Celgene; Eisai; Genentech/Roche; Merrimack; Vicus Therapeutics
Research Funding - Agios; ARIAD; ArQule; FibroGen; MedImmune; Senhwa Biosciences; Taiho Pharmaceutical; TRACON Pharma
 
Bin Zhang
Employment - Ipsen
 
Bruce Belanger
Employment - Ipsen; Merrimack
 
Floris A de Jong
Employment - Shire
Stock and Other Ownership Interests - Amgen; Shire
 
Stephan Braun
Employment - Ipsen; Parexel
Stock and Other Ownership Interests - Ipsen